Question 1

Does Geode Capital Management own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Geode Capital Management holds 967,172 shares of AXSM (Axsome Therapeutics), worth $236.8M.

Question 2

How many shares of AXSM does Geode Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Geode Capital Management holds 967,172 shares of AXSM (Axsome Therapeutics).

Question 3

What is Geode Capital Management's AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, Geode Capital Management's AXSM position is worth $236.8M.

Question 4

Is Geode Capital Management buying or selling AXSM?

Accepted Answer

In Q2 2026, Geode Capital Management reduced its AXSM position by 195,809 shares (-16.8%).

Question 5

When did Geode Capital Management first buy AXSM?

Accepted Answer

Geode Capital Management already held AXSM in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	967,172	-16.8%	$236.8M	0.0%	$244.77	0
2026-Q1	Increased	1.2M	+15.1%	$196.6M	0.0%	$169.02	35
2025-Q4	Increased	1M	+1.3%	$184.5M	0.0%	$182.64	31
2025-Q3	Increased	997,700	+0.8%	$121.2M	0.0%	$121.45	30
2025-Q2	Increased	989,453	+5.8%	$103.3M	0.0%	$104.39	32
2025-Q1	Increased	934,853	+2.5%	$109.1M	0.0%	$116.63	31
2024-Q4	Increased	912,538	+0.5%	$77.2M	0.0%	$84.61	30
2024-Q3	Increased	908,459	+2.7%	$81.7M	0.0%	$89.87	31